Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue, leading to fragile bones that break easily. It is categorized based on bone mineral density measurements compared to young adults. Symptoms include severe back pain from collapsed vertebrae fractures, loss of height, and bone deformities. Diagnosis involves bone density scans. Risk factors include hereditary factors, menopause, lack of exercise, low calcium/vitamin D, smoking, medications, and medical conditions. Nursing priorities are mobility impairment, nutritional imbalances, and knowledge deficits. Management includes education, exercise, nutrition, fall prevention, and drug therapies like bisphosphonates, monoclonal antibodies, hormones, and bone building medications
Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue, leading to fragile bones that break easily. It is categorized based on bone mineral density measurements compared to young adults. Symptoms include severe back pain from collapsed vertebrae fractures, loss of height, and bone deformities. Diagnosis involves bone density scans. Risk factors include hereditary factors, menopause, lack of exercise, low calcium/vitamin D, smoking, medications, and medical conditions. Nursing priorities are mobility impairment, nutritional imbalances, and knowledge deficits. Management includes education, exercise, nutrition, fall prevention, and drug therapies like bisphosphonates, monoclonal antibodies, hormones, and bone building medications
Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue, leading to fragile bones that break easily. It is categorized based on bone mineral density measurements compared to young adults. Symptoms include severe back pain from collapsed vertebrae fractures, loss of height, and bone deformities. Diagnosis involves bone density scans. Risk factors include hereditary factors, menopause, lack of exercise, low calcium/vitamin D, smoking, medications, and medical conditions. Nursing priorities are mobility impairment, nutritional imbalances, and knowledge deficits. Management includes education, exercise, nutrition, fall prevention, and drug therapies like bisphosphonates, monoclonal antibodies, hormones, and bone building medications
● Systemic skeletal disease characterized by low bone 1. Impaired physical mobility related to bone loss mass and microachriectual deterioration of bone tissue 2. Imbalanced nutrition: less than body requirement that leads to increased bone fragility and susceptibility related to inadequate calcium and vitamin D to fracture 3. Deficient knowledge related to lack of exposure to ● Categories of osteoporosis: information regarding medication, dietary ○ Normal modifications and safe activity program ■ Value for bone mineral content (BMC) is not more than 1.0 standard NURSING MANAGEMENT/ INTERVENTION deviation (SD) below young adult ● Promote understanding of osteoporosis and the mean value treatment regimen ○ Low bone mass (osteopenia) ● Advise patient to rest in bed in a supine or side lying ■ Value for BMC lied between 1.0 to position several times a day to relieve pain 2.5 SD below young adult mean ● Encourage the patient to intake adequate calcium and value vitamin d ○ Osteoporosis ● Encourage walking and regular weight bearing ■ BMC is more than 2.5 SD below the exercises to enhance the production of vitamin D young adult value ● Encourage the patient to avoid tobacco and alcohol ○ Severe osteoporosis ● Instruct the patient regarding estrogen replacement ■ BMC is more than 2.5 SD below the therapy young adult value and presence of ● Inform the patient regarding dietary calcium and one or more fragility fracture vitamin D ● Administer food high in fiber and increase fluids to FOCUS ASSESSMENT (SIGNS AND SYMPTOMS) prevent constipation ● Severe back pain caused by fractures of collapsed vertebra MEDICAL/ SURGICAL INTERVENTION ● Loss of height ● Joint replacement ● Progressive vertebral deformities ○ Replace all or part of a joint with a prosthesis ● Changes in appearance ● Closed or open reduction with internal fixation ○ Open- implants to guide the healing process of DIAGNOSTIC AND LABORATORY TEST a bone ● Bone density scan ○ Closed- to set or reduce a broken bone without ○ Used to measure bone mineral density surgery ○ Commonly performed using dual energy x- ray absorptiometry (DXA) DRUG ANALYSIS ● Calcium and vitamin D supplements RISK FACTORS ● Bisphosphonates ● Hereditary ○ Increase bone mass and decrease bone loss by ● Low body weight (<127 lbs) inhibiting osteoclast function ● Prolonged premenopausal amenorrhea or early ■ Alendronate, risedronate, menopause ibandronate, zoledronic ● Inadequate physical activity ● Monoclonal antibody medications ● Low intake of dietary calcium ○ Decrease bone resorption, increase BMD and ● Suboptimal level of vitamin D reduce the risk of fracture ● Smoking and alcohol intake ○ Administered intradermally every 6 months ○ Suppress osteoblast activity ■ Denosumab ● Certain medication such as: ● Hormone related therapy ○ Steroids, thyroid hormone, anti- convulsants, ○ Help maintain bone density in menopausal calcium channel blockers, NSAIDS women ● Certain medical conditions such as: ■ Estrogen, raloxifene ○ Celiac disease, IBD, cancer, rheumatoid ● Calcitonin arthritis ○ Inhibits osteoclasts thereby reducing bone loss ● Fragility fracture resulting from low trauma and increasing bone mineral density ● Osteopenia ● Bone building medication ○ Used when other common treatment cannot be tolerated ■ Teriparatide- stimulates new bone growth ■ Abaloparatide ■ Romosozumab